Closure Medical (CLSR) fomerly Tri-Point Medical (TPMC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Closure Medical (CLSR) fomerly Tri-Point Medical (TPMC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David S. who wrote (132)	4/7/1998 6:57:00 AM
From: JYatsu	Read Replies (1) of 184

Oh I neglected to mention that J&J is launching its internal lung sealant with another small company called Focal. This is available in Europe only but the clinical trials for the US market are underway. I don't think this will be as big a market as Dermabond but there is a market. If you ever had a patient with a airleak following lung surgery, and all you could do is wait it out. You would see that the market for this product is in preventing airleaks and thereby decreasing hospitalization rates. The insurance companies will be all for it. So I guess my point is that if J&J are investors in Dermabond/CLSR, its good enough for me. They (J&J) have expertise and time to evaluate these companies and products that we don't have. So Merry Xmas back at yah.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next